Artemis Bridge Beijing

Beijing Policy & Investment Gateway

National Policy Hub CCPFL Doctrine 16 Nations 3 Strategic Divisions

Rothschild Beijing serves as the policy and investment hub for the Artemis Bridge™ ecosystem — facilitating high-level dialogue between global capital and China's strategic priorities. 20 years in China. 99+ institutional partners. 333 proprietary intelligence reports.

20 Years in China 99+ Institutional Partners 333 Intelligence Reports 3 Strategic Divisions

Investment Thesis — Why Partner with Rothschild

20

Years in China

Two decades of trusted relationships with government agencies, state-owned enterprises, and institutional partners across China.

99+

Institutional Partners

Aggregated across our Hydrogen, Biotech, and Space divisions — spanning state-owned primes, private OEMs, and R&D institutions.

333

Intelligence Reports

Proprietary research covering energy transition, life sciences, aerospace policy, and strategic market analysis for institutional investors.

📈 Strategic Advantage

Beijing serves as the policy gateway — facilitating institutional introductions, regulatory dialogue, and national-scale project collaboration across our three divisions.

🤝 Institutional Access

Direct access to government agencies, think-tanks, state-owned enterprises, and institutional investors through our Beijing policy hub.

CCPFL Doctrine

Five principles guiding our policy work and investment approach in China.

C
Class
Dignity · Refinement · Education
C
Culture
Heritage · Tradition · Global
P
Polite Society
Dialogue · Respect · Civility
F
Family
Generations · Stewardship
L
Legacy
Archive · Future · Eternal

Artemis Bridge Divisions

Three strategic divisions powering the Artemis Bridge™ ecosystem.

⚡ Hydrogen Division

33+ Partners — Green hydrogen energy policy and investment coordination across China's energy transition landscape.

State-owned Private OEM R&D Institute Energy Prime

→ Click card to visit division site

🧬 Biotech Division

33+ Partners — Life sciences policy bridging global pharmaceutical innovation with China's healthcare ecosystem.

Pharma Prime Regulatory Biotech Research Institute

→ Click card to visit division site

🛰️ Space Division

33+ Partners — Aerospace policy for low-altitude economy, aviation corridors, and space technology development.

Aerospace Prime Tech Innovator Research Center National Lab

→ Click card to visit division site

Total Ecosystem: 99+ Institutional Partners across 16 nations and 5 continents.

Intelligence Library

333 proprietary intelligence reports.

🌱 Energy Transition

Policy perspectives on hydrogen, carbon neutrality, and sustainable infrastructure in China and globally.

133 Reports

🧬 Life Sciences

Cross-border frameworks for peptide therapeutics, clinical innovation, and biotech regulatory strategy.

100 Reports

🛰️ Aerospace Strategy

Policy dialogue on low-altitude economy, aviation corridors, and space technology development.

100 Reports

333 Reports Available to Qualified Institutional Partners

Contact Beijing Hub

🏛️ Beijing Policy Hub

Virtual HQ — Policy & Investment

📧 beijing@rothschildcorp.com

💬 +86-189-2244-4800

Institutional liaison hub.

🏭 Chengdu-Anren Operations

Physical Headquarters

333 Yingbin Road Section 1
Anren Town, Dayi, Chengdu
Sichuan 611330, PRC

📧 corp@rothschildcorp.com

Disclaimer: Rothschild Beijing represents the Austrian branch of the Rothschild family, operating independently in China.